Trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane
C16H32O2Si2 — CID 11347501
Data last refreshed: (MolForge compound catalog, from PubChem)
About Trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane
Trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane (PubChem CID 11347501) has the molecular formula C16H32O2Si2 and a molecular weight of 312.60 g/mol. Its IUPAC name is trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane.
Molecular Properties
| Compound Name | Trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane |
|---|---|
| PubChem CID | 11347501 |
| Molecular Formula | C16H32O2Si2 |
| Molecular Weight | 312.60 g/mol |
| Exact Mass | 312.19 |
| IUPAC Name | trimethyl-[[(1R,4S)-1,7,7-trimethyl-3-trimethylsilyloxy-2-bicyclo[2.2.1]hept-2-enyl]oxy]silane |
| SMILES | CC1(C)[C@@H]2CC[C@@]1(C)C(O[Si](C)(C)C)=C2O[Si](C)(C)C |
| InChI | InChI=1S/C16H32O2Si2/c1-15(2)12-10-11-16(15,3)14(18-20(7,8)9)13(12)17-19(4,5)6/h12H,10-11H2,1-9H3/t12-,16+/m1/s1 |
| InChIKey | AYWIHLVSPVPYQC-WBMJQRKESA-N |
| XLogP | 5.36 |
| TPSA | 18.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 312.60 |
| LogP ≤ 5 | 5.36 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 11347501 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.